Care Pathways

17.05.18

UK risks being ‘second-tier state’ for drugs without post-Brexit EMA deal, MPs say

The government must “protect the UK’s status as a world leader for pharmaceuticals” in a future made uncertain by the ongoing Brexit negotiations, MPs have said today.

A report released by the Business, Energy and Industrial Strategy Committee (BEIS) argued that leaving the European Union without an agreement for the industry would diminish access to markets that bring £11.9bn of worth of exports to the economy and significantly impact the cost of drugs imported in from the EU.

No deal between both sides would risk a “hugely damaging effect” on the procurement of drugs coming in from the EU, of which the Union supplies almost three-quarters of the nation’s entire drug imports demanded by Brits.

The MPs said: “As a highly-regulated industry, the prospect of regulator divergence from the European Medicines Agency (EMA) is the deepest concern for the industry. Without a continued relationship, there is a significant risk of the UK being a second-tier state for new and innovative medicines.

“There are no benefits from regulatory divergence and no prospect of the industry being able to fully manage any divergence required in the time available for transition,” the report wrote.

If the UK departs from EMA regulations, the committee claimed the release of a new drug could cost as much as £45,000, putting the nation’s attractiveness for top pharmaceutical companies and professionals in doubt.

MPs called upon the government to keep the UK in the EMA as a priority when entering the Brexit negotiations. They concluded: “We have sought out any potential benefits to the UK pharmaceutical sector from Brexit, but found that any small gains would be hugely outweighed by additional costs or the loss of access to existing, successful markets.

“The best potential we found for the UK to remain and grow as a world leader in the development, manufacture and regulation of pharmaceuticals is to maintain as close as possible a relationship with the EU as possible.”

Rachel Reeves MP, chair of the BEIS Committee, said: “The government’s own analysis identifies pharmaceuticals as the sector for which UK/EU market access is the most important given the industry is reliant on friction-free border movement for their products. Any delays at the border faced by short-life pharmaceuticals for emergency treatments would have a hugely detrimental impact on patients.

“Some form of membership of the EMA is vital to the continued success of the pharma industry and to the welfare of British patients, and the government should strike a deal to keep some of the organisation’s jobs and facilities in the UK, to continue to share our world-leading expertise.”

Peter Ballard, chair of the British Generic Manufacturers Association, said the organisation fully supports the report’s key finding that Whitehall must secure a post-Brexit deal for the pharma industry “ensuring the closest possible regulatory alignment with the EU and the minimum border friction possible,” or else it risks harming patients.

“There is a real risk that the UK becomes a second tier country behind the US and the EU with the launch of new medicines being delayed due to different regulatory rules,” he concluded.

Image Credit: artisteer, iStock images

Enjoying NHE? Subscribe here to receive our weekly news updates or click here to receive a copy of the magazine!

Comments

There are no comments. Why not be the first?

Add your comment

 

national health executive tv

more videos >

latest healthcare news

Lack of progress around growing waiting list could fuel surge in negligence claims against the NHS

22/03/2019Lack of progress around growing waiting list could fuel surge in negligence claims against the NHS

A rise in negligence claims against the NHS has been predicted by the government’s spending watchdog as it warns that “insufficient p... more >
Department of Health announces day surgery shake-up in Northern Ireland

22/03/2019Department of Health announces day surgery shake-up in Northern Ireland

The Department of Health (DoH) has announced “radical plans” to shake up day surgery across Northern Ireland. Thousands of routi... more >
‘Impossible’ for healthcare trust to remain open with 280 jobs set to go

22/03/2019‘Impossible’ for healthcare trust to remain open with 280 jobs set to go

A 150-year-old private health trust has announced it will have to close, with all services and 280 staff expected to be lost. All Hallows He... more >

editor's comment

25/09/2017A hotbed of innovation

This edition of NHE comes hot on the heels of this year’s NHS Expo which, once again, proved to be a huge success at Manchester Central. A number of announcements were made during the event, with the health secretary naming the second wave of NHS digital pioneers, or ‘fast followers’, which follow the initial global digital e... read more >

last word

Hard to be optimistic

Hard to be optimistic

Rachel Power, chief executive of the Patients Association, warns that we must be realistic about the very real effects of continued underfunding across the health service. It’s now bey... more > more last word articles >

the scalpel's daily blog

Personal Health Budgets: empowering individuals

20/03/2019Personal Health Budgets: empowering individuals

Jon Baker, PHBChoices director at NHS Shared Business Services (NHS SBS) believes that the extension of Personal Health Budgets (PHBs) is a great opportunity for clinical commissioning groups (CCG) to expand and improve care provision – provided that the right infrastructure is in place. The personalisation agenda is transforming ou... more >
read more blog posts from 'the scalpel' >

comment

Staying curious with the Shadow Board Programme

20/03/2019Staying curious with the Shadow Board Programme

Kirstie Stott, director of The Inspiring Leaders Network, discusses organisational and system curiosity alongside the work of the Shadow Board Pr... more >
Fiction as Therapy

20/03/2019Fiction as Therapy

Elaine Bousfield of ZunTold Publishing – a press specialising in fiction for children and young people – discusses ‘Fiction as ... more >
Capturing funds for the NHS estate

20/03/2019Capturing funds for the NHS estate

Aahsan Rahman, department head of town planning at NHS Property Services (NHSPS), looks at an alternative and perhaps underutilised funding sourc... more >
The digital revolution for healthcare is now!

20/03/2019The digital revolution for healthcare is now!

Richard Corbridge, chief digital & information officer at Leeds Teaching Hospitals NHS Trust, focuses on the practices his trust has put in p... more >

interviews

How can winter pressures be dealt with? Introduce a National Social Care Service, RCP president suggests

24/10/2018How can winter pressures be dealt with? Introduce a National Social Care Service, RCP president suggests

A dedicated national social care service could be a potential solution to surging demand burdening acute health providers over the winter months,... more >
RCP president on new Liverpool college building: ‘This will be a hub for clinicians in the north’

24/10/2018RCP president on new Liverpool college building: ‘This will be a hub for clinicians in the north’

The president of the Royal College of Physicians (RCP) has told NHE that the college’s new headquarters based in Liverpool will become a hu... more >
Duncan Selbie: A step on the journey to population health

24/01/2018Duncan Selbie: A step on the journey to population health

The NHS plays a part in the country’s wellness – but it’s far from being all that matters. Duncan Selbie, chief executive of Pu... more >
Cutting through the fake news

22/11/2017Cutting through the fake news

In an era of so-called ‘fake news’ growing alongside a renewed focus on reducing stigma around mental health, Paul Farmer, chief exec... more >

health service focus

View all News